Account for EUBIJ content access
Login / Register
Login / Register
About the Report
This report is primarily concerned with developments, market trends and regulations within the Japanese cell technology, cell therapy, tissue engineering and gene therapy sectors. It begins by outlining Japan's academic landscape and key research hubs within these various fields. It then analyses in detail the Japanese Society for Regenerative Medicine and also examines Japanese government policy and regulations regarding this topic. This report also provides a comparative analysis of EU, Japanese and US regulations, as well as a list of opportunities, access points and potential obstacles for EU SMEs hoping to enter this market in Japan.
About the Expert
Professor Rolf Schmid is a consultant with over 40 years’ experience in biotechnology-related R&D and business. Click here to access his profile.
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
